2025 PROSTATE CANCER
PATIENTS & CAREGIVERS VIRTUAL
CONFERENCE

SATURDAY NOV. 1ST, 2025 | 8:00 AM PDT

WATCH THE CONFERENCE FROM HOME

CLICK ON THE VIDEO ABOVE TO WATCH!

This virtual event features presentations from our 2025 in-person conference by world-renowned physicians who specialize in various aspects of prostate cancer care.

Gain insights on a wide range of topics, from the latest treatments and technologies to supportive care strategies. The conference culminates in a lively and extended Q&A session featuring Mark Moyad, MD and Mark Scholz, MD, who answer questions submitted during our conference, offering expert guidance in an open, engaging format.

Don’t miss this opportunity to be informed, inspired, and supported by the prostate cancer community!

 SPEAKERS

ELISABETH HEATH, MD

ADVANCED TREATMENTS
& SIDE EFFECTS

MATTHEW COOPERBERG, MD

ACTIVE SURVEILLANCE, GENETIC TESTING, BIOMARKERS & MORE

JOHN MULHALL, MD

ERECTILE DYSFUNCTION, TESTOSTERONE DEFICIENCY, & PEYRONIE’S DISEASE

AMAR KISHAN, MD

RADIATION & SIDE EFFECTS
MARK MOYAD, MD

ROBERT NEWTON, PHD

THE POWER OF EXERCISE FOR ALL PROSTATE CANCER PATIENTS

MARK MOYAD, MD, MPH

HOST & MODERATOR

MARK SCHOLZ, MD

EXTENDED Q+A & HOST

 AGENDA

SATURDAY, NOVEMBER 1, 2025

8:00am - 8:35am / Opening Remarks / Alex Scholz

8:35am - 9:35am / Advanced Treatments & Mitigating Side Effects | Elisabeth Heath, MD & Mark Moyad, MD, MPH

9:35am - 10:40pm / Erectile Dysfunction, Testosterone Deficiency, & Peyronie’s Disease | John Mulhall, MD & Mark Moyad, MD, MPH

10:40am - 11:40am / The Power of Exercise for all Prostate Cancer Patients | Robert Newton, PhD & Mark Moyad, MD, MPH

11:40am - 12:00pm / Award Ceremonies: The Harry Pinchot Awarded to Mark Lichty & The Bob Each Awarded to Jonathan Levy

12:00pm -1:00pm / Active Surveillance, Genetic Testing, Biomarkers & More | Matthew Cooperberg, MD & Mark Moyad, MD, MPH

1:00pm -2:00pm / Radiation & Side Effects | Amar Kishan, MD & Mark Moyad, MD, MPH

2:00pm -2:30pm / How To Win An Insurance Denial | Alex Scholz & Mark Moyad, MD, MPH | Marquis Ballroom

2:30pm -5:00pm / 2025 Conference Review & Extended Q+A / Mark Moyad, MD, MPH & Mark Scholz, MD

*Agenda subject to change

EXHIBIT HALL

Bayer is a global life sciences leader in healthcare and nutrition. Building on a 150-year legacy in healthcare, Bayer is committed to improving patient lives by developing therapies and delivering first-in-class educational and support programs to meet their needs.

This information has been reviewed according to the US law and is consistent with US Prescribing Information and is intended for US audience only. Prescribing Information may vary depending on local approval in each country.

Click here to learn more about Xofigo (radium Ra 223 dichloride)

Click here to learn more about NUBEQA (darolutamide)


For additional information, contact:

Rebecca Cowens-Alvarado, MPH

Deputy Director Advocacy Relations

Email: Rebecca.cowens-Alvarado@bayer.com

EDUCATIONAL RESOURCES

Living With Cancer Website:

https://www.thisislivingwithcancer.com/living-with-app

Pfizer Virtual Booth:

http://pfizeroncologycongressresources.com

Living With Cancer iTunes App:

https://apps.apple.com/us/app/id1223073769

Know Your Prostate Plan – Patient Videos

https://www.knowyourprostateplan.com/patient-stories

Click here for Full Prescribing Information

CLICK HERE TO DOWNLOAD THE BROCHURE

PROSTOX genetic tests help prostate cancer patients choose the safest form of radiation treatment

These tests predict a patient’s risk of late, long-term side effects following two radiation treatment approaches for prostate cancer, based on the number of fractions a patient will receive:

  • PROSTOX ultra: for 5-7 fractions (sessions) given over 10 days, and called stereotactic body radiotherapy (SBRT)

  • PROSTOX CFRT: for 35-45 fractions (sessions) given over 8-10 weeks

Patient Information and Access

Find out if you’re eligible to access PROSTOX testing through MiraKind and learn more: https://mirakind.org/prostox-testing/

Clinical evidence and Information for physicians

https://miradx.com/prostox

PAN FOUNDATION

We help underinsured people with life-threatening, chronic and rare diseases get the medications and treatments they need by assisting with their out-of-pocket costs and advocating for improved access and affordability.

RESOURCES:

OUR SPONSORS

PCRI RESOURCES

LEARN ABOUT ALL THAT PCRI HAS TO OFFER

The PCRI provides resources for prostate cancer patients and caregivers looking to gain understanding, insight, and hope. Get honest answers from science based data.

We are the Prostate Cancer Research Institute (PCRI), a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for you. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website or call us at 1 (800) 641-7274 with any question that you have.  Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. 
DONATE TO PCRI

OUR ADVOCACY PARTNERS

A special thank you to all of our incredible advocacy partners!

We encourage all prostate cancer patients and their care-partners to explore the incredible resources provided by the other advocacy groups we've listed below. These organizations offer invaluable support, information, and community that can make a significant difference in your journey. The Prostate Cancer Research Institute deeply appreciates the remarkable work of these groups and extends our heartfelt thanks to them for their dedication and contributions. Your involvement with these groups can provide additional strength and guidance, enhancing your path to better health.

THANK YOU FOR JOINING US!